Loar Holdings Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Loar Holdings Inc. on May 13, 2025, with the latest event reported on May 19, 2025. The filing details a secondary offering of common stock by selling shareholders and a related waiver of lock-up restrictions for key executives.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and shareholder transactions.
- Offered Shares: 9,000,000 shares of common stock.
- Option Shares: 1,350,000 additional shares (fully exercised by underwriters).
- Total Shares Sold: 10,350,000 shares.
- Public Offering Price: $83.41 per share.
- Company Proceeds: $0 (All shares were sold by Selling Shareholders).
Material Changes
The primary material change is the execution of a secondary offering and the modification of existing lock-up agreements:
- Lock-Up Waiver: On May 13, 2025, the Company and Principal Investors entered into a Waiver to the Registration Rights Agreement. This waived the "Additional Lock-up" for President/CEO Dirkson Charles and Executive Co-Chairman Brett Milgrim, allowing them to sell shares pro rata with other investors until September 30, 2027.
- Secondary Offering: An underwritten offering was conducted with Jefferies LLC and Morgan Stanley & Co. LLC as representatives. The closing for the Offered Shares occurred on May 16, 2025, and the Option Shares closed on May 19, 2025.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of new risks or contingencies beyond the standard indemnification provisions in the Underwriting Agreement. The transaction is a capital event for existing shareholders rather than a primary capital raise for the Company.
Key Facts for Investor Verification
- Verify the dilution impact on existing shareholders from the sale of 10,350,000 shares by selling shareholders.
- Confirm the identity of the "Selling Shareholders" in Schedule II of the Underwriting Agreement to assess potential changes in ownership concentration.
- Note that the Company received no proceeds from this transaction; funds went directly to the selling shareholders.
- Review the specific terms of the Waiver to the Registration Rights Agreement (Exhibit 10.1) to understand remaining restrictions on executive share sales.